Autologous bone marrow transplantation and hyperbaric oxygen therapy for patients with thromboangiitis obliterans

Angiology

Volumn 58, Issue 4, 2007, Pages 429-434

  Saito, Shigeru ^a   Nishikawa, Koichi ^a   Obata, Hideaki ^a   Goto, Fumio ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTERY DISEASE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BUERGER DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERBARIC OXYGEN; LIMB ISCHEMIA; MALE; MONONUCLEAR CELL; OXYGEN TENSION; SYMPTOM;

AGED; ANGIOGRAPHY; BONE MARROW TRANSPLANTATION; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED; OXIMETRY; PLETHYSMOGRAPHY; THROMBOANGIITIS OBLITERANS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 34548134529     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319706292015     Document Type: Article

References (21)

1. Rosenfield K., Isner JM: Disease of peripheral vessels. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia: Lippincott-Raven ; 1998: 2597-2620.
2. Mills JL: Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 16: 179-189, 2003.
3. Zhang WW, Harris LM, Shenoy SS,, et al. Outcomes of patients with atherosclerotic upper extremity tissue loss. Vasc Endovasc Surg 39: 33-38, 2005.
4. Diehm DC: Non-invasive treatment of critical limb ischemia. Curr Drug Targets Cardiovasc Haematol Disord 4: 241-247, 2004.
5. Isner JM, Pieczek A., Schainfeld R.,, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb. Lancet 348: 370-374, 1996.
6. Isner JM, Baumgartner I., Rauh G.,, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 28: 964-973, 1998.
7. Morishita R., Aoki M., Hashiya N.,, et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44: 203-209, 2004.
8. Lederman RJ, Mendelsohn FO, Anderson RD,, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359: 2053-2058, 2002.
9. Tateishi-Yuyama E., Matsubara H., Murohara T.,, et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427-435, 2002.
10. Rutherford RB, Baker JD, Ernst C.,, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26: 517-538, 1997.
11. Pomposelli FB Jr, Arora S., Gibbons GW,, et al. Lower extremity arterial reconstruction in the very elderly: successful outcome preserves not only the limb but also residential status and ambulatory function. J Vasc Surg 28: 215-225, 1998.
12. Asahara T., Murohara T., Sullivan A.,, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.
13. Shintani S., Murohara T., Ikeda H., et al: Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103: 897-903, 2001.
14. Asahara T., Takahashi T., Masuda H.,, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972, 1999.
15. Takahashi T., Kalka C., Masuda H.,, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999.
16. Zamboni WA: The microcirculation and ischemia reperfusion: basic mechanisms of hyperbaric oxygen. In: Kindwall EP, Whelan HT, eds. Hyperbaric Medicine Practice. 2 nd ed. Flagstaff, AZ: Best Publishing ; 2002: 779-794.
17. Hammarlund C.: The physiologic effects of hyperbaric oxygenation. In: Kindwall EP, Whelan HT, eds. Hyperbaric Medicine Practice. 2 nd ed. Flagstaff, AZ: Best Publishing ; 2002: 37-68.
18. Garcia-Covarrubias L., McSwain NE Jr, Van-Meter K., Bell RM Adjuvant hyperbaric oxygen therapy in the management of crush injury and traumatic ischemia: an evidence-based approach. Am Surg 71: 144-151, 2005.
19. Kudchodkar BJ, Wilson J., Lacko A., Dory L.: Hyperbaric oxygen reduces the progression and accelerates the regression of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 20: 1637-1643, 2000.
20. Kinnaird T., Stabile E., Burnett MS, Epstein SE: Bone-marrow-derived cells for enhancing collateral development: mechanism, animal data, and initial clinical experiences. Circ Res 95: 354-363, 2004.
21. Lei Y., Haider HKh, Shujia J, Sim ES: Therapeutic angiogenesis. Devising new strategies based on past experiences. Basic Res Cardiol 99: 121-132, 2004.